NCQA Guidelines and the KDIGO Heat Map in CKD Management

Author(s):

Rajiv Agarwal, MD,Mark A. Meeker, DO, FACP, CPE

Key Takeaways

Identifying at-risk patients for CKD in Type 2 Diabetes involves assessing hypertension, family history, and blood glucose levels.
Screening tests for CKD include eGFR and UACR, essential for early detection in diabetic patients.
Early CKD detection allows timely intervention, slowing disease progression and reducing cardiovascular risks.
CKD is a significant risk factor for heart failure, highlighting the importance of early detection for cardiovascular risk management.

Panelists discuss how NCQA guidelines apply to chronic kidney disease (CKD) management and the role of the KDIGO heat map in enhancing clinical practice.

How do NCQA guidelines apply to CKD management, and what is the KDIGO heat map's role in clinical practice?